Clarus Therapeutics shares are trading lower after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market.
Clarus Therapeutics Shares Are Trading Lower After the Company Announced It Has Received a Non-compliance Letter From Nasdaq. The Shares Will Be Suspended on August 31st and Will Begin Trading on the OTC Pink Market.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.